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Abstract 
Objective: Oligodendrocytes account for myelination in the central nervous system. During myelin compaction, key 
proteins are translated in the vicinity of the myelin membrane, requiring targeted mRNA transport. Quaking isoform 
6 (QKI6) is a STAR domain-containing RNA transport protein, which binds a conserved motif in the 3′-UTR of certain 
mRNAs, affecting the translation of myelination-involved proteins. RNA binding has been earlier structurally character-
ized, but information about full-length QKI6 conformation is lacking. Based on known domains and structure predici-
tons, we expected full-length QKI6 to be flexible and carry disordered regions. Hence, we carried out biophysical and 
structural characterization of human QKI6.
Results: We expressed and purified full-length QKI6 and characterized it using mass spectrometry, light scattering, 
small-angle X-ray scattering, and circular dichroism spectroscopy. QKI6 was monodisperse, folded, and mostly dimeric, 
being oxidation-sensitive. The C-terminal tail was intrinsically disordered, as predicted. In the absence of RNA, the 
RNA-binding subdomain is likely to present major flexibility. In thermal stability assays, a double sequential unfolding 
behaviour was observed in the presence of phosphate, which may interact with the RNA-binding domain. The results 
confirm the flexibility and partial disorder of QKI6, which may be functionally relevant.
Keywords: Myelin sheath, Protein stability, RNA-binding protein, Circular dichroism, SAXS
© The Author(s) 2019. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creat iveco mmons .org/licen ses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Introduction
In the central nervous system, long axonal segments 
undergo myelination by oligodendrocytes (OGs), forming 
the basis of rapid nerve impulse conduction. OGs extend 
their processes and wrap their plasma membrane around 
axons in a process driven by actin disassembly [1]. The 
plasma membrane stacks undergo compaction driven by 
factors like myelin basic protein (MBP) in the cytoplasm 
[2]. The translation of MBP and other proteins involved 
in myelination has to occur close to the membranes that 
undergo stacking [2, 3]. To achieve this, mRNAs coding 
for these proteins are trafficked along OG processes. Dis-
ruption of this trafficking results in dysmyelination, aber-
rant myelin formation [4–6].
The protein Quaking (QKI) manifests as several alter-
natively spliced cytosolic isoforms, the dominant ones 
being QKI5, QKI6, and QKI7 [7, 8]. The domain struc-
ture of QKI consists of a STAR (signal transduction and 
activation of RNA) domain, which is further divided 
into an N-terminal QUA1 dimerization domain, and 
KH (K-homology) and QUA2 domains that together 
are responsible for binding to specific 3′-UTR targets in 
mRNAs [9]. An additional 100 amino acids follow in the 
C terminus, capped by an isoform-specific stretch, which 
contains a nuclear localization signal in QKI5, absent in 
QKI6 and QKI7 [7, 9, 10]. QKI7 can induce apoptosis in 
OGs, and heterodimerization of QKI5 and QKI7 results 
in nuclear localization, suppressing apoptotic activity 
[11]. QKI6 functions in translational repression, being 
essential for OG myelination [7, 12, 13]. Lack of QKI 
in OGs disrupts the trafficking of myelination-related 
mRNAs [14], producing an aberrant myelin phenotype 
and related neurological issues, as demonstrated by the 
quakingviable mouse model [7, 15].
Structural studies on the QUA1 domain and its Xeno-
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by hydrophobic interactions [16, 17], and solution NMR 
studies on the KH-QUA2 region demonstrated independ-
ent folding of the two domains, which lacked major con-
tacts with one another [18]. The crystal structure of the 
entire STAR domain bound to a synthetic oligonucleotide 
was solved, uncovering the 3′-UTR binding mode and the 
involved binding determinants [19]. In this structure, the 
KH-QUA2 region was well defined, suggesting that in the 
absence of RNA, its flexibility might have relevance in 
sensing binding motifs. Modelling studies indicated that 
the absence of RNA increases the STAR domain dynam-
ics [20]. Structures of other homologous proteins have 
revealed KH-mediated dimerization, whereby the QUA1 
domain also forms dimers, but disordered linkers join 
QUA1 to the KH domain [21]. To date, only the STAR 
domain of QKI has been structurally characterized, and 
the remaining regions of full-length QKI remain obscure.
We set out to study the hypothesis, based on previous 
structural studies and predictions, that full-length QKI6 
is a flexible, partially disordered molecule. Full-length 
human QKI6 is a homodimeric protein with indepen-
dently folded subdomains and an elongated C terminus. 
Its thermal stability and unfolding behaviour are affected 





A bacterial expression construct coding for human QKI6 
(UniProt: Q96PU8-9, amino acids 1–319) with an N-ter-
minal tobacco etch virus (TEV) protease digestion site 
[22] was generated using Gateway cloning in the pTH27 
vector [23].
Bioinformatics
Secondary structure prediction of the QKI6 construct 
was performed using psipred [24, 25]. The molecular 
weight (35,187.8  Da) and pI (7.10) were calculated with 
ProtParam [26].
Protein expression and protein purification
QKI6 was expressed in E. coli BL21(DE3) using ZYM-
5052 autoinduction at 37  °C for 24  h [27]. Cells were 
harvested by centrifugation and resuspended in wash-
ing buffer (50  mM Tris–HCl, 300  mM NaCl, 50  mM 
 (NH4)2SO4, 20  mM imidazole, 0.5  mM tris(2-carbox-
yethyl)phosphine (TCEP), pH 8.0) supplemented with 
0.1  mg/ml lysozyme and cOmplete EDTA-free protease 
inhibitor cocktail (Roche). Suspensions were snap-frozen 
in liquid  N2 and stored at − 80 °C until purification.
The cell suspension was lysed using ultrasonication. 
The lysate was clarified by centrifugation, and the soluble 
fraction was subjected to standard Ni-nitrilotriacetic acid 
(NTA) chromatography. The above-mentioned washing 
buffer was used and supplemented with 500  mM imi-
dazole to elute bound proteins. His tags were removed 
using TEV protease [22] during overnight dialysis against 
imidazole-free washing buffer.
The digested protein was subjected to a second Ni–
NTA chromatography. The unbound fraction was gel 
filtrated using a Superdex 200 16/60 HiLoad (GE Health-
care) column with 20  mM Tris–HCl, 300  mM NaCl, 
1% (w/v) glycerol, pH 8.0 as running buffer. The puri-
fied protein was either used fresh, or frozen in liquid  N2 
and stored at − 80 °C. 0.5 mM TCEP was included, after 
QKI6 was found to be oxidation-sensitive (see below).
Mass spectrometry
The molecular mass of QKI6 was determined using a 
Micromass Q-Tof 2 after desalting using liquid chroma-
tography. 0.5  mM TCEP was added to study oxidation 
sensitivity. The identity of QKI6 was verified using pep-
tide fingerprinting and a Bruker Ultra fleXtreme mass 
analyzer.
Multi‑angle light scattering
Monodispersity and molecular weight of QKI6 were 
determined using size exclusion chromatography-multi-
angle light scattering (SEC-MALS). The chromatography 
was performed using an Äkta Purifier (GE Healthcare) 
and a Superdex 200  pg increase 10/300GL (GE Health-
care) column with 20  mM Tris–HCl, 300  mM NaCl, 
0.5 mM TCEP, pH 8.0 as mobile phase. A 200-µg QKI6 
sample was injected into the column at 0.4 ml/min and 
light scattering recorded using a Wyatt miniDAWN 
TREOS instrument. Concentration was determined 
using an on-line refractometer (Shodex RI-101). Data 
were analyzed using ASTRA (Wyatt).
Synchrotron radiation circular dichroism spectroscopy
Synchrotron radiation circular dichroism (SRCD) data 
were collected from 0.6  mg/ml QKI6 in 10  mM Na 
phosphate, pH 7.0 on the UV-CD12 beamline (ANKA, 
Karlsruhe, Germany) [28]. A closed circular cell (Supra-
sil, Hellma Analytics) of 100-µm pathlength was used for 
spectra recorded from 180 to 280 nm at 10  °C. Baseline 
subtraction and unit conversion were done with CDtoolX 
[29].
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Thermal stability
The thermal stability of QKI6 was determined by differ-
ential scanning fluorimetry (DSF) as described [30–32]. 
We screened the effect of salt and pH combined with 
selected additives. A temperature range of 20–90 °C was 
scanned with an Applied Biosciences 7500 PCR system. 
The melting temperature midpoints (Tm) were extracted 
from the curves. Every condition was measured in dupli-
cate and contained 0.1 mg/ml QKI6.
Small‑angle X‑ray scattering
Small-angle X-ray scattering (SAXS) data were collected 
from 2.3 to 9.0  mg/ml samples in 50  mM Tris–HCl, 
300  mM NaCl, 1% glycerol, 1  mM 2-mercaptoethanol, 
pH 7.5. Data collection was performed on the P12 beam-
line, EMBL/DESY (Hamburg, Germany). Monomeric 
bovine serum albumin was used as a molecular weight 
standard (I0 = 12,981.7; 66.5  kDa). Data reduction, pro-
cessing, and analysis were performed using BioXTAS 
RAW [33] and ATSAS [34]. Distance distribution func-
tions were determined using GNOM [35]. Ab initio mod-
eling was performed with GASBOR [36] and flexible 
loops and termini were modeled using CORAL [37]. Data 
processing, analysis, and modelling details are listed in 
Additional file 1: Table S1.
Results and discussion
We hypothesized that full-length QKI6 is flexible and 
partly disordered. Hence, we carried out a low-resolu-
tion characterization of human QKI6 in solution in the 
absence of bound RNA.
Full-length QKI6 appeared mostly as a single band on 
SDS-PAGE and a major peak in SEC-MALS (Fig.  1a), 
with an absolute molecular weight of 76 kDa, indicating 
dimeric state. Some tetramer was present, which might 
be a disulphide artifact. Mass spectrometry confirmed 
the correct monomeric mass of QKI6 in reducing condi-
tions (Table  1). Under non-reducing conditions, several 
masses were observed (Table 1), which decreased to the 
expected one when TCEP was added. This indicates oxi-
dation sensitivity: the lowest mass could correspond to 
an intermolecular disulphide bond, as the mass is 1  Da 
less per monomer. For the remaining peaks, other amino 
acids need to be considered. QKI6 contains two Cys and 
13 Met, and several Met reside in the QUA1 and QUA2 
domains (Fig.  1b). The measured mass difference could 
arise from the oxidation of some Met residues, since the 
mass increment is 16 Da.
DSF was used to screen the impact of salt and buffer 
on the Tm of QKI6 (Fig.  1c). QKI6 was most stable in 
slightly alkaline conditions, peaking at 57–59 °C at pH 
8.0. At pH 6.0, melting occurred early, in a heteroge-
neous manner. The presence of 150–300  mM NaCl 
further increased Tm. Phosphate changed the unfold-
ing landscape of QKI6 by introducing a second melting 
event at 71  °C. The effect was reproducible in slightly 
alkaline conditions and not observed with other buffers 
(Additional file 1: Fig. S1). Phosphate ions might inter-
act with the RNA-binding cleft of QKI6, stabilizing a 
population or a region of the protein.  (NH4)2SO4, while 
having a slight stabilizing effect, only presented a single 
melting event (Fig. 1c).
Secondary structure prediction of QKI6 suggested that 
the C-terminal third is unstructured (Fig.  1b). SRCD 
measurements of QKI6 produced a spectrum typical 
for a folded protein, but the minimum at 205  nm sug-
gested the presence of disorder (Fig.  2a). This drove us 
to characterize QKI6 using SAXS (Fig. 2b–h, Additional 
file  1: Table  S1). The dimeric QKI6 was highly flexible, 
as evident from the Kratky plot (Fig. 2c), and elongated, 
based on its radius of gyration (Rg, 5.24  nm) and maxi-
mum dimension (Dmax, 21  nm). Ab  initio models based 
on the SAXS data appear elongated with a compact core 
(Fig. 2e). Within this core, the individual subdomains of 
the STAR domain could be fitted in, but only if separated 
from one another, implying that the crystal structure 
may not represent the conformation of the STAR domain 
without bound mRNA.
To verify the flexibility of the STAR domain, we 
used CORAL to model the missing parts of the pro-
tein (Fig. 2f–h). First, we prepared a theoretical dimeric 
model, where we superposed two STAR domains (PDB 
ID: 4jvh [19]) on a QUA1 dimer (PDB ID: 4dnn [16]). 
Then, we performed the analysis in three sets: a dimer of 
the STAR domain with all subdomains fixed in place (set 
1), a fixed dimeric QUA1 domain with linkers to mobile 
KH-QUA2 units (set 2), and a fixed dimeric QUA1 
domain with linkers connecting fully mobile KH and 
QUA2 subdomains (set 3). The C-terminal region was 
built as dummy residues. Based on the results, we could 
clearly exclude set 1 (Fig. 2b, f ), χ2 being high. In sets 2 
and 3, the KH-QUA2 subdomains were clearly separated 
from the QUA1 dimer, implying a high degree of flexibil-
ity. In both sets, the χ2 values were much lower (Fig. 2b, 
g–h). The differences between sets 2 and 3 are marginal, 
as SAXS cannot distinguish the movement of a single 
helix (QUA2) with respect to the KH subdomain within 
the entire protein. Nevertheless, KH and QUA2 are likely 
to be mobile with respect to each other [18]. This is sup-
ported by the fact that the KH-QUA2 unit could not be 
fitted well within the GASBOR model, but the two sub-
domains had to be separated (Fig. 2e). In all three model-
ling sets, the 115 C-terminal residues were extended, in 
agreement with secondary structure predictions. To con-
clude, in the absence of an mRNA binding partner, the 
subdomains of dimeric QKI6 present a great degree of 
Page 4 of 7Raasakka and Kursula  BMC Res Notes          (2019) 12:609 
flexibility with respect to each other and most likely col-
lapse to a more ordered arrangement upon binding to a 
3′-UTR. The STAR domain is followed by an intrinsically 
disordered C terminus of currently unknown function.
Conclusions
We performed a structural characterization of full-length 




Fig. 1 Properties of QKI6. a SEC-MALS profile of QKI6 displays mainly a dimer. The purity of QKI6 was determined using SDS-PAGE (inset). b Top: 
The sequence of QKI6. Secondary structure prediction is shown below the sequence. The C-terminal tail (underlined) has not been structurally 
characterized. Cys and Met residues are highlighted in bold. Bottom: Crystal structure of the QKI6 STAR domain in complex with an RNA 
oligonucleotide (PDB ID: 4jvh [19]) is presented with the subdomains annotated. Coloring matches the protein sequence. The RNA oligonucleotide 
(5′-ACU AAC AA-3′) is shown as gray sticks. Cys and Met residues are shown as sticks. c Thermal stability experiments of QKI6 reveal that its Tm is 
increased in elevated pH and moderate salt content. Additionally, phosphate produces another melting event at ~ 71 °C. Each condition was 
measured twice. All pH values were tested in the absence of NaCl. All salt concentrations were tested in 50 mM BICINE, pH 8.0. The effect of 
additives was tested in 50 mM BICINE, pH 8.0, 150 mM NaCl
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domain is likely to be flexible, with QUA1 separated from 
KH-QUA2 by a flexible linker. Phosphate changes the 
thermal unfolding behaviour of QKI6, possibly by inter-
acting with the RNA-binding site. The role of the disor-
dered C terminus is ambiguous, and further studies are 
required to understand its function in vivo.
Table 1 Mass determination of  QKI6 in  different redox 
conditions
a Δmass = massnon-reducing − massreducing
Condition Determined mass (Da) Δmass (Da)
a
0.5 mM TCEP 35,186.5 –
Non-reducing 35,185.5 − 1.0
35,321.0 + 134.5
35,337.0 + 134.5 + 16







Fig. 2 Structure of QKI6. a SRCD spectrum of QKI6 reveals significant secondary structure content. b SAXS data (open circles) with analysis fits 
(lines). The inset shows the Guinier region, with a linear fit (solid line). c Kratky plot of QKI6 displays high flexibility. d Distance distribution diagram 
from GNOM. e GASBOR Ab initio model (gray surface) of QKI6 is elongated. The QUA1, QUA2, and KH subdomain crystal structures have been 
individually placed inside the model. f CORAL model with the fully fixed STAR domain crystal structure (PDB ID: 4jvh [19]) and modelled loops and 
termini (set 1), g fixed QUA1 subdomain dimer with respect to mobile KH-QUA2 subdomains (set 2), and h fully separated mobile QUA2 and KH 
subdomains, with only a fixed QUA1 dimer (set 3). In all CORAL models, the QUA1 dimerization is fixed and based on the crystal structure of QUA1 
(PDB ID: 4dnn [16]). In e–h, all QKI subdomains are colored as in Fig. 1b
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Limitations
The structural characterization employed low-resolution 
methods, preventing analysis of the fine molecular details 
of QKI6. Furthermore, as the molecule is flexible, the 
shown 3D conformations are single snapshots of con-
formations in the whole ensemble. All experiments here 
were performed without RNA partners, and it is there-
fore unclear, exactly how phosphate stabilizes QKI6.
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org/10.1186/s1310 4-019-4629-x.
Additional file 1: Table S1. Small-angle X-ray scattering parameters and 
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